Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)

v3.20.2
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Net sales $ 204,199 $ 183,243
Cost of sales 66,468 64,829
Gross margin 137,731 118,414
Operating expenses:    
Selling, general and administrative 72,598 69,010
Research and development 16,041 16,077
Total operating expenses 88,639 85,087
Operating income 49,092 33,327
Other (expense) income (9,753) (15,521)
Earnings before income taxes 39,339 17,806
Income taxes 5,944 3,408
Net earnings 33,395 14,398
Other comprehensive income (loss):    
Foreign currency translation adjustments 11,914 (7,602)
Derivative instruments - cash flow hedges (Note 7) 2,143 (504)
Other comprehensive income (loss) 14,057 (8,106)
Comprehensive income $ 47,452 $ 6,292
Earnings per share:    
Basic (in dollars per share) $ 0.87 $ 0.38
Diluted (in dollars per share) $ 0.83 $ 0.37
Weighted average common shares outstanding:    
Basic (in shares) 38,536 38,032
Diluted (in shares) 40,025 39,253